Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture

Journal of the American College of Cardiology

Volumn 29, Issue 7, 1997, Pages 1536-1541

  Caplice, Noel M ^a   Aroney, Constantine N ^b   Bett, J H Nicholas ^b   Cameron, James ^b   Campbell, Julie H ^a   Hoffmann, Nancy ^a   McEniery, Paul T ^b   West, Malcolm J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR;

ADULT; AGED; ANGIOPLASTY; ARTICLE; ATHERECTOMY; BLOOD VESSEL INJURY; CELL PROLIFERATION; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; MITOGENICITY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; BETA-THROMBOGLOBULIN; CELL DIVISION; CELLS, CULTURED; CORONARY CIRCULATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; MITOGENS; MUSCLE, SMOOTH, VASCULAR; PLATELET ACTIVATION; PLATELET FACTOR 4; PLATELET-DERIVED GROWTH FACTOR;

EID: 0030914774     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00076-4     Document Type: Article

References (22)

1. Holmes DR, Vlietstra RR, Smith HS, et al. Restenosis after percutaneous transluminal coronary angioplasty a report from the PTCA registry of the National Heart, Lung, and Blood Institute . Am J Cardiol. 53:1984;77C-81C.
2. Nobuyoshi M, Kimuna T, Nosaka H, et al. Restenosis after successful percutaneous transluminal angioplasty serial angiographic follow-up of 299 patients . Am J Cardiol. 12:1988;616-623.
3. Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB. Primary peripheral arterial stenosis and restenosis excised by transluminal atherectomy a histopathologic study . J Am Coll Cardiol. 15:1990;419-425.
4. Schwartz SM, de Blois D, O'Brien ER. The intima soil for atherosclerosis and restenosis . Circ Res. 77:1995;445-465.
5. Barrett TB, Benditt EP. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA. 85:1988;2870-2874.
6. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988;82:1134-3.
7. Hughes SE, Crossmann D, Hall PE. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res. 27:1993;1214-1219.
8. Ferns GA, Raines EW, Sprugel KH, et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1991;1129-1131.
9. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA. 88:1991;3739-3743.
10. Liu MW, Roubin GS, Robinson KA, et al. Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circ. 81:1990;1089-1093.
11. Maresta A, Barducelli M, Cantini L, et al. Trapidil, a platelet-derived growth factor antagonist, reduces restenosis after angioplasty results of the randomized double-blind STARC study . Circ. 90:1994;2710-2715.
12. Fisher LD, van Belle G. Biostatistics. 1993;Wiley, New York.
13. Scharf RE, Power A, Marzec UM, et al. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries flow cytometric detection . Atheroscler Thromb. 12:1992;1475-1487.
14. Dartsch PC, Voisard R, Bauriedel G, Hofling B, Betz E. Growth characteristics and cytoskeletal organisation of cultured smooth muscle cells from human primary stenosing and restenosing lesions. Arteriosclerosis. 10:1990;62-75.
15. Soyombo AA, Di Corleto PE. Stable expression of human platelet-derived growth factor β chain by bovine aortic endothelial cells - matrix association and selective cleavage. J Biol Chem. 269:1994;17734-17740.
16. Crowley ST, Ray CJ, Nawaz D, Majack RA, Horwitz LD. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol. 269:1995;H1641-H1647.
17. Raines EW, Ross R. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J Cell Biol. 116:1992;533-543.
18. Khachigian IM, Owensby DA, Chesterman CN. A tyrosinated peptide representing the alternatively spliced exon of the platelet-derived growth factor A chain binds specially to culture cells and interferes with binding of several growth factors. J Biol Chem. 267:1992;1660-1666.
19. Kelly JL, Sanchez A, Brown GS, Chesterman CN, Sleigh MJ. Accumulation of PDGF B and cell binding forms of PDGF A in the extracellular matrix. J Cell Biol. 121:1993;1153-1163.
20. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries interaction of heparin with basic fibroblast growth factor . J Clin Invest. 90:1992;2044-2049.
21. Golino P, Piscione F, Benedict LR, et al. Local effect of serotonin released during coronary angioplasty. N Engl J Med. 330:1994;523-528.
22. Nichols AB, Owen J, Grossman BA, et al. Effect of heparin binding on catheter-induced fibrin formation and platelet activation. Circulation. 70:1984;843-850.